Siemens Healthcare Private Limited names Hariharan Subramanian as the Managing Director
Takes over the new role effective July 1, 2023, from Vivek Kanade, who takes over other responsibilities within the organization He leads the business for Siemens Healthineers in India including, manufacturing, sales, and distribution,
- Takes over the new role effective July 1, 2023, from Vivek Kanade, who takes over other responsibilities within the organization
- He leads the business for Siemens Healthineers in India including, manufacturing, sales, and distribution, strategy for “Zone India”, comprising neighboring countries like Bangladesh, Nepal, Sri Lanka, Bhutan, and Maldives.
Hariharan Subramanian (49) has been named as the Managing Director of Siemens Healthcare Private Limited (SHPL), India, effective July 1, 2023. SHPL is the wholly owned subsidiary company of the global MedTech company, Siemens Healthineers AG (listed in Frankfurt, Germany: SHL).
He leads the business for Siemens Healthineers India including, manufacturing, sales, and distribution, strategy for “Zone India”, comprising neighboring countries like Bangladesh, Nepal, Sri Lanka, Bhutan, and Maldives.
During his association of over 25 years with Siemens, he has held leadership positions in Finance, Business Administration, Enterprise Services, and Sales functions across Software engineering, IT Consulting, and Healthcare business. Before assuming responsibilities of Zone India in May 2023, he was the Head of Sales for the Diagnostic Imaging and Advanced Therapy businesses in India.
He has been leading the team in Zone India towards the common goal of pioneering breakthroughs in healthcare, for everyone, everywhere, so that therapy becomes more precise and affordable, value is at the heart of care delivery, patients are treated as consumers, healthcare becomes digital and in turn, we improve access to care.
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion. Further information is available at www.siemens-healthineers.com.
Siemens Healthineers in India has a countrywide sales network and round-the-clock service set-up, two manufacturing facilities at Vadodara for Diagnostics and at Bengaluru for Medical Imaging Products, backed by a state-of-the-art R&D center as well as a global software development center at Bengaluru. With over 3,900 employees across the nation, we are playing a significant role in transforming care delivery in India and supporting healthcare providers across the entire range of patient care – from prevention and early detection to diagnosis and on to treatment and aftercare. Further information is available at www.siemens-healthineers.co.in